Literature DB >> 21350202

Hemorrhagic transformation of childhood arterial ischemic stroke.

Lauren A Beslow1, Sabrina E Smith, Arastoo Vossough, Daniel J Licht, Scott E Kasner, Christopher G Favilla, Aviva R Halperin, Danielle M Gordon, Charlene I Jones, Andrew J Cucchiara, Rebecca N Ichord.   

Abstract

BACKGROUND AND
PURPOSE: The objective of this study was to describe the occurrence of hemorrhagic transformation (HT) among children with arterial ischemic stroke within 30 days after symptom onset and to describe clinical factors associated with HT.
METHODS: Sixty-three children aged 1 month to 18 years with arterial ischemic stroke between January 2005 and November 2008 were identified from a single-center prospective pediatric stroke registry. All neuroimaging studies within 30 days of stroke were reviewed by a study neuroradiologist. Hemorrhage was classified according to the European Cooperative Acute Stroke Study-1 definitions. Association of HT with clinical factors, systemic anticoagulation, stroke volume, and outcome was analyzed.
RESULTS: HT occurred in 19 of 63 children (30%; 95% CI, 19% to 43%), only 2 (3%) of whom were symptomatic. Hemorrhage classification was hemorrhagic infarction (HI)1 in 14, HI2 in 2, parenchymal hematoma (PH)1 in 2, and PH2 in 1. HT was less common in children with vasculopathy (relative risk, 0.27; 95% CI, 0.07 to 1.06; P=0.04) than in those with other stroke mechanisms. HT was not significantly associated with anticoagulation versus antiplatelet therapy (relative risk, 0.6; 95% CI, 0.2 to 1.5; P=0.26) but was associated with larger infarct volumes (P=0.0084). In multivariable analysis, worse Pediatric Stroke Outcome Measure scores were associated with infarct volume ≥5% of total supratentorial brain volume (OR, 4.0; 95% CI, 1.1 to 15; P=0.04), and a trend existed toward association of worse Pediatric Stroke Outcome Measure scores with HT (OR, 4.0; 95% CI, 0.9 to 18; P=0.07).
CONCLUSIONS: HT occurred in 30% of children with arterial ischemic stroke within 30 days. Most hemorrhages were petechial and asymptomatic. Infarct volume was associated with HT and worse outcome.

Entities:  

Mesh:

Year:  2011        PMID: 21350202      PMCID: PMC3066279          DOI: 10.1161/STROKEAHA.110.604199

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  18 in total

1.  Neurologic outcome in survivors of childhood arterial ischemic stroke and sinovenous thrombosis.

Authors:  G A deVeber; D MacGregor; R Curtis; S Mayank
Journal:  J Child Neurol       Date:  2000-05       Impact factor: 1.987

2.  Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II).

Authors:  V Larrue; R von Kummer R; A Müller; E Bluhmki
Journal:  Stroke       Date:  2001-02       Impact factor: 7.914

3.  Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators.

Authors: 
Journal:  JAMA       Date:  1998 Apr 22-29       Impact factor: 56.272

4.  The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1997-05-31       Impact factor: 79.321

5.  Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort.

Authors:  M Fiorelli; S Bastianello; R von Kummer; G J del Zoppo; V Larrue; E Lesaffre; A P Ringleb; S Lorenzano; C Manelfe; L Bozzao
Journal:  Stroke       Date:  1999-11       Impact factor: 7.914

6.  Lesion volume, lesion location, and outcome after middle cerebral artery territory stroke.

Authors:  V Ganesan; V Ng; W K Chong; F J Kirkham; A Connelly
Journal:  Arch Dis Child       Date:  1999-10       Impact factor: 3.791

7.  Diffusion-weighted imaging and National Institutes of Health Stroke Scale in the acute phase of posterior-circulation stroke.

Authors:  I Linfante; R H Llinas; G Schlaug; C Chaves; S Warach; L R Caplan
Journal:  Arch Neurol       Date:  2001-04

8.  Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study.

Authors:  V Larrue; R von Kummer; G del Zoppo; E Bluhmki
Journal:  Stroke       Date:  1997-05       Impact factor: 7.914

9.  Risk of stroke in children: ethnic and gender disparities.

Authors:  Heather J Fullerton; Yvonne W Wu; Shoujun Zhao; S Claiborne Johnston
Journal:  Neurology       Date:  2003-07-22       Impact factor: 9.910

10.  Antithrombotic treatments, outcomes, and prognostic factors in acute childhood-onset arterial ischaemic stroke: a multicentre, observational, cohort study.

Authors:  Neil A Goldenberg; Timothy J Bernard; Heather J Fullerton; Anne Gordon; Gabrielle deVeber
Journal:  Lancet Neurol       Date:  2009-10-02       Impact factor: 44.182

View more
  23 in total

1.  Children with post-stroke epilepsy have poorer outcomes one year after stroke.

Authors:  Christine K Fox; Lori C Jordan; Lauren A Beslow; Jennifer Armstrong; Mark T Mackay; Gabrielle deVeber
Journal:  Int J Stroke       Date:  2018-06-29       Impact factor: 5.266

Review 2.  Neuroprotective Mechanisms of Melatonin in Hemorrhagic Stroke.

Authors:  Hai-Jian Wu; Cheng Wu; Huan-Jiang Niu; Kun Wang; Lian-Jie Mo; An-Wen Shao; Brandon J Dixon; Jian-Min Zhang; Shu-Xu Yang; Yi-Rong Wang
Journal:  Cell Mol Neurobiol       Date:  2017-01-28       Impact factor: 5.046

3.  Approach to acute ischemic stroke in childhood.

Authors:  Catherine Amlie-Lefond; Joan Cox Gill
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-01

4.  Socioeconomic determinants of outcome after childhood arterial ischemic stroke.

Authors:  Lori C Jordan; Nancy K Hills; Christine K Fox; Rebecca N Ichord; Paola Pergami; Gabrielle A deVeber; Heather J Fullerton; Warren Lo
Journal:  Neurology       Date:  2018-07-06       Impact factor: 9.910

5.  The Pediatric Stroke Recurrence and Recovery Questionnaire: validation in a prospective cohort.

Authors:  Warren D Lo; Rebecca N Ichord; Michael M Dowling; Mubeen Rafay; Jeffrey Templeton; Aviva Halperin; Sabrina E Smith; Daniel J Licht; Mahendranath Moharir; Rand Askalan; Gabrielle Deveber
Journal:  Neurology       Date:  2012-08-15       Impact factor: 9.910

6.  Incidence of Recurrence in Posterior Circulation Childhood Arterial Ischemic Stroke.

Authors:  Michael Y Uohara; Lauren A Beslow; Lori Billinghurst; Brianna M Jones; Sudha K Kessler; Daniel J Licht; Rebecca N Ichord
Journal:  JAMA Neurol       Date:  2017-03-01       Impact factor: 18.302

Review 7.  Hemorrhagic transformation after ischemic stroke in animals and humans.

Authors:  Glen C Jickling; DaZhi Liu; Boryana Stamova; Bradley P Ander; Xinhua Zhan; Aigang Lu; Frank R Sharp
Journal:  J Cereb Blood Flow Metab       Date:  2013-11-27       Impact factor: 6.200

8.  Vascular PDGFR-alpha protects against BBB dysfunction after stroke in mice.

Authors:  Quang Linh Nguyen; Noriko Okuno; Takeru Hamashima; Son Tung Dang; Miwa Fujikawa; Yoko Ishii; Atsushi Enomoto; Takakuni Maki; Hoang Ngoc Nguyen; Van Tuyen Nguyen; Toshihiko Fujimori; Hisashi Mori; Johanna Andrae; Christer Betsholtz; Keizo Takao; Seiji Yamamoto; Masakiyo Sasahara
Journal:  Angiogenesis       Date:  2020-09-12       Impact factor: 9.596

9.  GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats.

Authors:  Wei Wang; Mingchang Li; Yuefei Wang; Qian Li; Gang Deng; Jieru Wan; Qingwu Yang; Qianxue Chen; Jian Wang
Journal:  Mol Neurobiol       Date:  2015-12-15       Impact factor: 5.590

Review 10.  Hypertension and childhood stroke.

Authors:  Juan C Kupferman; Marc B Lande; Stella Stabouli; Dimitrios I Zafeiriou; Steven G Pavlakis
Journal:  Pediatr Nephrol       Date:  2020-04-29       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.